Who gets paid for what? Slow progress on EU PV fees
This article was originally published in SRA
Despite the radical changes made by the European Commission to its proposals for a new pharmacovigilance fee structure, a number of outstanding issues remain to be resolved before the draft regulation can be approved.
You may also be interested in...
A project is about to begin to understand the factors that influence marketing decisions in the various EU member states.
EU trade expert Hervé Jouanjean considers the reasoning behind the EU’s vaccine procurement approach and Italy's decision to block exports of AstraZeneca's COVID-19 vaccine.
Coronavirus Notebook: Italy Makes First Use Of EU’s Vaccine Export Control System, More Regulators Issue Guidance On Variants
Ukraine has established a system for issuing emergency use authorizations for COVID-19 vaccines that recognizes authorizations granted by other world regulators.